Medical Marijuana, Inc. Congratulates Mexico’s President Nieto for April 21 Speech, Which Came After Permits Issued for RSHO-X™ as First-Ever Cannabis Product Approved for Import Into Mexico
San Diego, CA – April 25, 2016 – Medical Marijuana, Inc. (OTC: MJNA) is proud to announce to shareholders and the public that in an April 22 article entitled Mexican President Reverses Course, Now Supports Medicinal Marijuana, CNSNews.com reported that the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product is the first-ever cannabis product (high concentration natural botanical hemp-based cannabidiol (CBD) without THC) approved by federal authorities for import into Mexico, into what projects to be a “$10-12 billion” future cannabis market.
According to the CNSNews.com report, “The U.S. company Medical Marijuana Inc. received permission from Mexican authorities on Feb. 1 to export to Mexico one of its products used to treat epilepsy in children. The product doesn’t contain the psychoactive ingredient THC, according to the company’s CEO, Stuart Titus.”
“Titus predicted the market for medical marijuana products in Mexico could be as large as $10-12 billion annually,” the report continues. This would mirror the best industry estimates for the true size of the California medicinal marijuana marketplace – which has been estimated at $10 – $12 billion.
As first reported by Mexico’s health agency COFEPRIS and Reuters News Agency, families in Mexico are now able to import HempMeds® THC-free CBD hemp oil (RSHO-X™) with a government- issued permit. The decision by COFEPRIS and the historic April 21 speech from Mexico’s President Enrique Peña Nieto came after Medical Marijuana, Inc.‘s HempMeds® sponsored and participated with Raul Elizalde and the Por Grace Foundation in multiple public forums including the National Debates on Marijuana Use advocating for medical cannabis access in Mexico.
“The Washington Post has reported that the historic shift by Mexican President Nieto to support research and access to medical cannabis for the people of Mexico has furthered the movement to legalize medical marijuana throughout the Americas, building on the momentum from Canadian and
U.S. legal marijuana State initiatives,” states Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc. “Medical Marijuana, Inc. is very grateful to our hard-working team that has worked day-and-night to try to help affect global change and help the world change their view of cannabis in terms of medicinal application.”
“We are very proud and grateful to have worked with Raul Elizalde and the Por Grace Foundation as our premier charitable partner in Mexico. We’re honored to have welcomed his family into ours,” Titus continues. “Medical Marijuana, Inc. also congratulates Mexican President Nieto for inviting Elizalde, the father of little Grace, to speak alongside him at his April 21 speech. It was an extremely touching moment and a moment of historic importance, signifying the true end of the failed ‘War on Drugs’. We look forward to doing our very best to continue to help the people of Mexico to achieve access to all cannabinoids and cannabinoid products that may further their health and wellness.”
Since the historic decision by the government of Mexico, coverage of Medical Marijuana, Inc. and RSHO-X™ has included:
Norte Digital: http://nortedigital.mx/buscan-traer-chicle-cannabidiol/
Respuesta En Linea: http://www.respuestaenlinea.net/?p=39133
Fortune Magazine: http://fortune.com/2016/02/02/medical-marijuana-mexico/
Reuters México: http://mx.reuters.com/article/topNews/idMXL2N15H1Y7
Pulso de San Luis (Comunicado de prensa): http://pulsoslp.com.mx/2016/02/01/cofepris- autoriza-importacion-de-medicamento-con-cannabis-para-dos-ninas/
Despertar de Oaxaca (Comunicado de prensa): http://despertardeoaxaca.com/concede- cofepris-dos-permisos-para-productos-con-cannabidiol/
Notimundo (Comunicado de prensa): http://notimundo.com.mx/importan-cannabis-para- tratar-a-dos-ninas-autoriza-cofepris/
El Mañana de Nuevo Laredo: http://elmanana.com.mx/noticia/92016/Autorizan-a-dos-nias- tratamiento-con-mariguana.html
La Crónica de Hoy: http://www.cronica.com.mx/notas/2016/942796.html
(Photo caption: The Mexican Government Health Agency, COFEPRIS, issued two historic permits to import RSHO-X cannabidiol (CBD) hemp oil into Mexico in February.)
(Photo caption: RSHO-X cannabidiol (CBD) hemp oil from Medical Marijuana, Inc. is non-psychoactive and approved by Mexico for import with proper government documentation.)
About Medical Marijuana Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
The Company is committed to consistently providing the highest-quality CBD hemp oil products on the market. To see Medical Marijuana, Inc.’s video statement, click here. Shareholders are also encouraged to visit the Medical Marijuana, Inc. Shop for discounted products.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp- based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
For further information, please contact: Public Relations contact:
Corporate contact: Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)
Investor Relations: Nicholas R. Massalas
Director of Business Development Medical Marijuana Inc.
OTC Symbol: MJNA
Toll Free: (877) 964.6463
Direct: (858) 264-6505